Form D — Andson Biotech Inc.
0002017131-25-000004 · filed 2025-10-22
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $5,000,000
- Total sold
- $4,735,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Andson Biotech Inc.
- CIK
- 2017131
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 1705 COMMERCE DR NW
ATLANTA, GA 30318 - Phone
- 7273897725
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Mason Chilmonczyk · Executive OfficerAtlanta, GA Find on LinkedIn ↗
-
Andrei Fedorov · DirectorAtlanta, GA Find on LinkedIn ↗
-
Thomas O'Brien · DirectorAtlanta, GA Find on LinkedIn ↗
-
James Ross · DirectorAtlanta, GA Find on LinkedIn ↗
-
Jim Filippini · Executive OfficerAtlanta, GA Find on LinkedIn ↗
-
Glenn Epstein · DirectorAtlanta, GA Find on LinkedIn ↗
View original on SEC EDGAR.